Kezar Life Sciences Inc.

NASDAQ: KZR · Real-Time Price · USD
3.97
-0.01 (-0.25%)
At close: Aug 15, 2025, 3:59 PM
4.07
2.52%
After-hours: Aug 15, 2025, 07:48 PM EDT

Kezar Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a -5.43M 7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 251K n/a 260K 261K 260K 280K 278K 249K 259K 13M 458K 431K 417K 387K 378K 373K 372K
Gross Profit
n/a -251K 521K -260K -261K -260K -280K 6.72M -249K -259K -13M -458K -431K -417K -387K -378K -373K -372K
Operating Income
-14.6M -17.63M -21.56M -21.95M -23.38M -23.71M -28.4M -25.53M -26.78M -24.52M -20.03M -18.93M -16.32M -15.88M -14.1M -14.5M -13.01M -13.05M
Interest Income
1.2M 1.42M 1.73M 2.04M 2.24M 2.45M 2.73M 2.82M 2.86M 2.69M 2.2M 1.39M 408K 108K 50K 37K 47K 54K
Pretax Income
-13.7M -16.56M -20.22M -20.31M -21.55M -21.66M -32.26M -23.1M -24.31M -22.2M -18.18M -17.85M -16.19M -16.02M -14.21M -14.46M -12.96M -12.99M
Net Income
-13.7M -16.56M -20.22M -20.31M -21.55M -21.66M -32.26M -23.1M -24.31M -20.24M -16.33M -16.77M -16.19M -16.17M -14.21M -14.46M -12.96M -12.99M
Selling & General & Admin
5.02M 5.45M 5.54M 5.71M 5.34M 6.28M 5.48M 8.79M 5.79M 6.21M 5.17M 5.07M 4.98M 4.93M 4.32M 3.97M 3.67M 3.76M
Research & Development
9.58M 12.18M 16.03M 16.24M 16.3M 17.17M 22.64M 23.74M 21M 18.32M 4.86M 13.86M 11.35M 10.94M 9.78M 10.53M 9.34M 9.29M
Other Expenses
n/a n/a -12K n/a n/a n/a n/a -278K n/a n/a 10M n/a n/a n/a 1K n/a n/a n/a
Operating Expenses
14.6M 17.63M 21.56M 21.95M 21.64M 23.45M 28.12M 32.25M 26.78M 24.52M 20.03M 18.93M 16.32M 15.88M 14.1M 14.5M 13.01M 13.05M
Interest Expense
302K 347K 389K 403K 401K 400K 399K 396K 385K 370K 349K 310K 272K 254K 159K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -261K -260K -280K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.6M 17.63M 21.56M 21.95M 23.38M 23.71M 34.59M 32.53M 26.78M 24.52M 20.03M 18.93M 16.32M 15.88M 14.1M 14.5M 13.01M 13.05M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.96M -1.85M -1.08M n/a 146K n/a -108K n/a n/a
Shares Outstanding (Basic)
7.31M 7.31M 7.3M 72.96M 72.88M 72.8M 72.74M 72.68M 72.46M 72.33M 72.23M 72.15M 64.28M 60.63M 55.98M 52.05M 51.9M 51.06M
Shares Outstanding (Diluted)
7.31M 7.31M 7.3M 72.96M 72.88M 72.8M 72.74M 72.68M 72.46M 72.33M 72.23M 72.15M 64.28M 60.63M 55.98M 52.05M 51.9M 51.06M
EPS (Basic)
-1.87 -2.27 -2.77 -0.28 -0.3 -0.3 -0.44 -0.32 -0.34 -0.28 -0.23 -0.23 -0.25 -0.27 -0.25 -0.28 -0.25 -0.25
EPS (Diluted)
-1.87 -2.27 -2.77 -0.28 -0.3 -0.3 -0.44 -0.32 -0.34 -0.28 -0.23 -0.23 -0.25 -0.27 -0.25 -0.28 -0.25 -0.25
EBITDA
-14.6M -15.96M -19.57M -19.65M -20.89M -21M -31.58M -22.43M -23.67M -21.65M -17.83M -17.08M -15.48M -15.43M -13.4M -14.12M -12.59M -12.62M
EBIT
-13.4M -16.21M -19.83M -19.91M -21.15M -21.26M -31.86M -22.71M -23.92M -21.83M -17.83M -17.54M -15.91M -15.77M -13.91M -14.46M -12.96M -12.99M
Depreciation & Amortization
n/a 251K 259K 260K 261K 260K 280K 278K 249K 259K -283K 458K 431K 417K 387K 378K 373K 372K